Association of Abnormal Glucose Metabolism and Inflammation With Prognosis in Patients With Acute Coronary Syndrome
ACS patients with abnormal glucose metabolism and high inflammation have a higher long-term MACE risk than those with normal glucose metabolism and low inflammation. Early guideline-directed medical therapy, alongside anti-inflammatory therapy and hypoglycemic agents, may improve long-term outcomes in this high-risk group.
Authors
- Wenjin Peng
- Meng Ning (ORCID: https://orcid.org/0000-0003-3883-7079)
- Chong Zhang (ORCID: https://orcid.org/0009-0006-1271-1637)
- Yi Chen (ORCID: https://orcid.org/0000-0003-4885-6097)
- Tianqi Wang (ORCID: https://orcid.org/0000-0002-1460-1013)
- Yingwu Liu (ORCID: https://orcid.org/0009-0001-0521-7044)
Institutions
- Nankai University (CN)
- Tianjin Third Central Hospital (CN)
- Cell Technology (China) (HK)
- Tianjin International Joint Academy of Biomedicine (CN)
- Tianjin Fire Research Institute (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Journal of Diabetes
- Published
- 2025-07-30
- DOI
- https://doi.org/10.1111/1753-0407.70134
- Citations
- 2
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 2.78